Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

72.23
Delayed Data
As of 4:01pm ET
 +0.46 / +0.64%
Today’s Change
50.57
Today|||52-Week Range
72.79
+34.93%
Year-to-Date
No recent news for Zoetis Inc.

Today’s Trading

Previous close71.77
Today’s open71.77
Day’s range71.64 - 72.66
Volume1,939,851
Average volume (3 months)2,328,871
Market cap$35.0B
Data as of 4:01pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+142.65%
Earnings growth (this year)+20.74%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+2.58%
P/E ratio38.0
Price/Sales5.46
Price/Book23.79

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+1.70+1.52%
BAXBaxter International...+0.17+0.27%
INCYIncyte Corp-1.85-1.90%
VRTXVertex Pharmaceutica...-0.77-0.54%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)$0.66
Annual revenue (last year)$4.9B
Annual profit (last year)$821.0M
Net profit margin16.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
New Jersey, New Jersey

Forecasts